organization · Reporting owner
LILLY ENDOWMENT INC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ELI LILLY & Co
Report date May 06, 2026 · Filed May 07, 2026
Section 16 reporting ended · disclosed 2026-05-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 91,881,150 |
Ending reported balance
After 2026-05-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-06 · Sale · Disposed 13,620 · Balance 91,883,358 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4. Row 2 · 2026-05-06 · Sale · Disposed 2,208 · Balance 91,881,150 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2020 Filed Apr 1, 2020 17:47 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 38,962 | $140.07 | $5,457,473.58 |
DisclosureSEC source: 0001209191-20-022039 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,271,342 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.44, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| March 30, 2020 Filed Mar 31, 2020 20:03 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 200 | $141.70 | $28,340.00 |
DisclosureSEC source: 0001209191-20-021790 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,310,304 Read SEC document |
| March 30, 2020 Filed Mar 31, 2020 20:03 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 19,026 | $140.90 | $2,680,759.59 |
DisclosureSEC source: 0001209191-20-021790 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,310,504 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.53 to $141.15, inclusive. Read SEC document |
| March 30, 2020 Filed Mar 31, 2020 20:03 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 55,965 | $139.97 | $7,833,460.23 |
DisclosureSEC source: 0001209191-20-021790 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,329,530 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.52 to $140.51, inclusive. Read SEC document |
| March 30, 2020 Filed Mar 31, 2020 20:03 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 55,973 | $138.98 | $7,778,954.02 |
DisclosureSEC source: 0001209191-20-021790 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,385,495 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.52 to $139.51, inclusive. Read SEC document |
| March 30, 2020 Filed Mar 31, 2020 20:03 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 78,836 | $138.16 | $10,892,044.83 |
DisclosureSEC source: 0001209191-20-021790 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,441,468 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.52 to $138.5125, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), and (4) to this Form 4. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 19:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 69,047 | $147.10 | $10,156,744.65 |
DisclosureSEC source: 0001209191-20-007128 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,520,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.905 to $147.34, inclusive. Read SEC document |
| February 05, 2020 Filed Feb 6, 2020 19:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 130,953 | $146.35 | $19,165,063.22 |
DisclosureSEC source: 0001209191-20-007128 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,589,351 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.90 to $146.85, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| January 13, 2020 Filed Jan 14, 2020 18:37 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 21,245 | $139.62 | $2,966,226.90 |
DisclosureSEC source: 0001209191-20-003268 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,720,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.33 to $139.97, inclusive. Read SEC document |
| January 13, 2020 Filed Jan 14, 2020 18:37 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 183,755 | $138.84 | $25,512,268.57 |
DisclosureSEC source: 0001209191-20-003268 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,741,549 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.33 to $139.32, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| January 10, 2020 Filed Jan 13, 2020 16:00 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 210,000 | $138.00 | $28,979,013.00 |
DisclosureSEC source: 0001209191-20-003164 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,925,304 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.70 to $138.27, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| January 09, 2020 Filed Jan 10, 2020 18:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 920 | $136.32 | $125,417.16 |
DisclosureSEC source: 0001209191-20-002979 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,135,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.31 to $136.36, inclusive. Read SEC document |
| January 09, 2020 Filed Jan 10, 2020 18:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 219,080 | $135.79 | $29,749,311.36 |
DisclosureSEC source: 0001209191-20-002979 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,136,224 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.31 to $136.3021, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| January 08, 2020 Filed Jan 9, 2020 19:04 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 30,434 | $134.04 | $4,079,342.93 |
DisclosureSEC source: 0001209191-20-002675 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,355,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.90 to $134.205, inclusive. Read SEC document |
| January 08, 2020 Filed Jan 9, 2020 19:04 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 142,216 | $133.17 | $18,938,762.50 |
DisclosureSEC source: 0001209191-20-002675 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,385,738 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.90 to $133.89, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| January 07, 2020 Filed Jan 8, 2020 16:33 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 32,645 | $132.90 | $4,338,579.26 |
DisclosureSEC source: 0001209191-20-002450 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,527,954 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.90 to $132.925, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| December 20, 2019 Filed Dec 23, 2019 14:48 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 19,705 | $132.90 | $2,618,812.23 |
DisclosureSEC source: 0001209191-19-061674 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,560,599 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.90 to $132.93, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| December 18, 2019 Filed Dec 19, 2019 19:36 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 163,014 | $129.45 | $21,101,999.29 |
DisclosureSEC source: 0001209191-19-061259 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,580,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.17 to $129.96, inclusive. Read SEC document |
| December 18, 2019 Filed Dec 19, 2019 19:36 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 56,986 | $128.84 | $7,341,848.30 |
DisclosureSEC source: 0001209191-19-061259 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,743,318 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.16 to $129.15, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| December 17, 2019 Filed Dec 18, 2019 16:31 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 34,182 | $126.60 | $4,327,577.93 |
DisclosureSEC source: 0001209191-19-061070 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,800,304 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.27 to $126.99, inclusive. Read SEC document |
| December 17, 2019 Filed Dec 18, 2019 16:31 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 110,527 | $125.81 | $13,905,733.45 |
DisclosureSEC source: 0001209191-19-061070 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,834,486 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.27 to $126.26, inclusive. Read SEC document |
| December 17, 2019 Filed Dec 18, 2019 16:31 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 70,291 | $125.06 | $8,790,241.01 |
DisclosureSEC source: 0001209191-19-061070 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,945,013 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.27 to $125.26, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 16:49 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 10,962 | $119.70 | $1,312,151.40 |
DisclosureSEC source: 0001209191-19-059788 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,015,304 Read SEC document |
| December 06, 2019 Filed Dec 9, 2019 14:51 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 400 | $120.70 | $48,280.00 |
DisclosureSEC source: 0001209191-19-059548 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,026,266 Read SEC document |
| December 06, 2019 Filed Dec 9, 2019 14:51 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 193,638 | $120.15 | $23,265,218.42 |
DisclosureSEC source: 0001209191-19-059548 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,026,666 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.70 to $120.69, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 18:31 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 210,000 | $118.52 | $24,890,040.00 |
DisclosureSEC source: 0001209191-19-059237 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,220,304 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.25 to $118.79, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 27, 2019 Filed Dec 2, 2019 18:40 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 48,953 | $117.51 | $5,752,256.53 |
DisclosureSEC source: 0001209191-19-058461 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,430,304 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.50 to $117.63, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 15:40 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 56,729 | $117.81 | $6,683,470.41 |
DisclosureSEC source: 0001209191-19-058247 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,479,257 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.50 to $118.08, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 16:19 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 109,318 | $117.60 | $12,855,796.80 |
DisclosureSEC source: 0001209191-19-058044 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,535,986 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.50 to $118.25, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 22, 2019 Filed Nov 25, 2019 21:29 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 222,577 | $116.31 | $25,888,821.18 |
DisclosureSEC source: 0001209191-19-057936 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,645,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.00 to $116.62, inclusive. Read SEC document |
| November 22, 2019 Filed Nov 25, 2019 21:29 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 29,159 | $115.74 | $3,374,775.18 |
DisclosureSEC source: 0001209191-19-057936 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,867,881 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.00 to $115.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 15:56 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 108,264 | $115.14 | $12,465,506.13 |
DisclosureSEC source: 0001209191-19-057722 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,897,040 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.00 to $115.51, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 19, 2019 Filed Nov 20, 2019 15:17 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 18,783 | $115.74 | $2,173,869.29 |
DisclosureSEC source: 0001209191-19-057390 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,005,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.50 to $116.12, inclusive. Read SEC document |
| November 19, 2019 Filed Nov 20, 2019 15:17 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 186,217 | $114.99 | $21,412,906.61 |
DisclosureSEC source: 0001209191-19-057390 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,024,087 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.50 to $115.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 17:00 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 10,598 | $114.00 | $1,208,172.00 |
DisclosureSEC source: 0001209191-19-057090 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,210,304 Read SEC document |
| November 12, 2019 Filed Nov 13, 2019 18:53 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 7,981 | $114.00 | $909,841.18 |
DisclosureSEC source: 0001209191-19-056299 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,220,902 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.00 to $114.02, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 11, 2019 Filed Nov 12, 2019 18:12 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 100 | $114.07 | $11,406.50 |
DisclosureSEC source: 0001209191-19-055942 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,228,883 Read SEC document |
| November 07, 2019 Filed Nov 8, 2019 15:35 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 400 | $114.37 | $45,749.00 |
DisclosureSEC source: 0001209191-19-055761 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,228,983 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.235 to $114.45, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 16:03 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 173,918 | $114.05 | $19,835,000.06 |
DisclosureSEC source: 0001209191-19-055605 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,229,383 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.00 to $114.26, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 04, 2019 Filed Nov 5, 2019 18:18 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 7,003 | $114.04 | $798,608.11 |
DisclosureSEC source: 0001209191-19-055125 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,403,301 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.00 to $114.115, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 14:37 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 7,593 | $114.55 | $869,808.52 |
DisclosureSEC source: 0001209191-19-054683 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,410,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.50 to $114.64, inclusive. F2 · balance_after: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.50 to $114.64, inclusive. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 14:37 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 182,407 | $113.98 | $20,789,837.83 |
DisclosureSEC source: 0001209191-19-054683 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,417,897 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.50 to $114.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. F1 · balance_after: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.50 to $114.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| September 20, 2019 Filed Sep 23, 2019 17:33 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 96,800 | $116.61 | $11,287,848.00 |
DisclosureSEC source: 0001209191-19-050426 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,600,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.42 to $117.23, inclusive. F2 · balance_after: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.42 to $117.23, inclusive. Read SEC document |
| September 20, 2019 Filed Sep 23, 2019 17:33 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 113,200 | $116.17 | $13,149,878.00 |
DisclosureSEC source: 0001209191-19-050426 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,697,104 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.42 to $116.415, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. F1 · balance_after: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.42 to $116.415, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| March 26, 2019 Filed Mar 27, 2019 18:57 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,714 | $132.02 | $490,311.14 |
DisclosureSEC source: 0001209191-19-021409 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,810,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.0153 to $132.0211, inclusive. Read SEC document |
| March 26, 2019 Filed Mar 27, 2019 18:57 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 201,286 | $131.40 | $26,448,376.54 |
DisclosureSEC source: 0001209191-19-021409 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,814,018 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.00 to $131.98, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 19:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 58,717 | $128.97 | $7,572,790.21 |
DisclosureSEC source: 0001209191-19-015363 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,015,304 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.85 to $129.345, inclusive. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 19:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 106,854 | $128.55 | $13,736,081.70 |
DisclosureSEC source: 0001209191-19-015363 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,074,021 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.85 to $128.84, inclusive. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 19:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 44,429 | $127.45 | $5,662,342.76 |
DisclosureSEC source: 0001209191-19-015363 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,180,875 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.845 to $127.84, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 18:25 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 33,200 | $127.45 | $4,231,472.80 |
DisclosureSEC source: 0001209191-19-014881 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,225,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.2472 to $127.6522, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.